Key facts
- It has raised $2.8M; the latest was Later Stage VC ($190K) in Dec 2025.
- Notable investors include Antler, Creative Destruction Lab, InnoFounder, Denmark's Export and Investment Fund, BioInnovation Institute — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for HHC Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for HHC Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HHC Medical
Operator of a health tech company intended to deliver localized genetic therapy. The company's platform develops technology for targeted and non-invasive drug delivery via electroporation, enabling doctors to transfect a large number of cells in a short time.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2019
- Employees
- 6
- Website
- hhc-medical.com/
- Ownership
- Privately Held (backing)
HHC Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HHC Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HHC Medical in its N-PORT filings yet. We sweep new filings monthly.